# COLUMBIA UNIVERSITY HEALTH SCIENCES: Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | COLUMBIA UNIVERSITY HEALTH SCIENCES |
| Location | NEW YORK, NY |
| Project | Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma |
| Project number | 7R01CA293456-03 |
| Mechanism | R01 |
| Institute | National Cancer Institute |
| Award | $532,605 |
| Awarded | 2026-08-27 |
| Project period | 2024-07-08 to 2027-06-30 |
| UEI | QHF5ZZ114M72 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11616958). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.